Supplementary Figure S7 from Practical Considerations for Using the TITE-BOIN Design to Handle Late-Onset Toxicity or Fast Accrual in Phase I Trials
Year: 2025
Type: supplementary-materials
Abstract: Comparative performances of TITE-BOIN designs with seven different cutoffs (A, B), denoted as TB(A, B), relative to the standard BOIN design under scenarios 1-6 with target DLT of 0.25. TB(A, B) requires that over A % of the patients treated at the current dose have completed the DLT window to make dose escalation or de-escalation decision, and that the last pending patient be followed for at least B % of the DLT window before making dose escalation decision
Language: English
Subfield: Statistics and Probability
Field: Mathematics
Domain: Physical Sciences
Open Access status: gold
OpenAlex ID: W4411908083
